AIMEDIS

AIMEDIS

image

Potential purchasers of Aimedis digital assets (as referred to in this whitepaper) must carefully consider and evaluate all risks and uncertainties associated with Aimedis, its assets, its subsidiary business, the companies’ operations, the asset offering, the AIMX tokens and all information presented in this whitepaper and the Aimedis business plan, the technical documents and all information provided on all Aimedis associated websites and social media presences.

In case any of these uncertainties, risks or problems develop into actual events, the companies, the business operations, the financial state of the companies, effect and results of Aimedis operations and material provided with Aimedis could be materially and adversely affected. In case of one of these events you might lose part or all of the value of the acquired assets.

This business plan and its contained information shall not be considered legal, financial, business, tax or investment advice concerning Aimedis and its assets and its associates’ businesses and operations. Please always advise your own tax advisor, your legal or any other professional advisor or your local authorities when you plan to participate in Aimedis. Please always be aware that you might bear the financial risks of any participation in Aimedis for an indefinite period.

The business plan you are reading does not represent an offer document of any kind or prospectus and is not intended to illustrate a solicitation for investment in securities or offer of securities in any jurisdiction.

INTRODUCTION

Aimedis is a Netherlands and UAE based company providing an innovative next-generation healthcare solution designed to connect patients to healthcare services and providers like doctors, hospitals and scientific research facilities.

While competitors exist in this space, Aimedis is one of the few companies with an operational platform to integrate latest blockchain technology alongside artificial intelligence (AI).

Aimedis is the only existing medical ecosystem combining professional healthcare knowledge with the swarm intelligence of patient communities. The Aimedis team has been working on multiple e-health projects since 2009 including a solution for the pharmaceutical industry. Our experiences combined with more than 12 years of clinical experience and experience in the pharmaceutical industry of the founders are integral components of the ecosystem. An ecosystem, which benefits both the patients and professionals in the medical field.

OVERVIEW OF AIMEDIS ECOSYSTEM

Ideally situated in the Netherlands, Dubai and the Philippines, Aimedis has a vast network of doctors and supporters who are actually establishing Aimedis as a key player in the healthcare environment, delivering services to a growing community of empowered patients.

Aimedis is offering international coding of diagnoses and medication correspondent to WHOstandards. Our unique solution includes seamless integration into the existing health IT environment and support for all major medical standards like HIPAA compliance, IHE compatibility, ISO certification, HL7/FHIR, SNOMED, LOINC, ICD-10, ATC and more. Besides Aimedis already is a registered medical product in the European Union. The Aimedis platform offers a complete e-health ecosystem consisting of several and expandable modules.

The entire platform is supported by our AIMChain 2.0 blockchain secured data structure which secures all parts and information that is shared and accessed in Aimedis. The ecosystem will use artificial intelligence in several ways (see Artificial Intelligence Supported Therapy, Diagnosis and Research).

The Aimedis ecosystem consists of the Aimedis patient centered platform, the professional platform, AIMSocial + user content (video and more), Aimedis Labs & Pharmacy, Medical Tourism applications, Aimedis records, video chat, prescriptions, second opinions, appointments and Aimedis Virtual Hospital, all available on web and mobile, multilingual and web responsive. This means Aimedis is not only a fully functional combination of a personal health record and an electronic medical record but it combines the HIPAA/IHE compliant EMR/PHR with a fully HIPAA compliant video bridge between doctors and patients, an electronic prescription module, an electronic appointment system, an electronic learning & teaching section, a medical video library, an AI backed big data evaluation, AI supported pharmaceutical treatments, a medical tourism platform and a social platform secured by our proprietary AIMChain blockchain to give patients security, 100% transparency and trust by securing each and every single transaction. This finally gives patients not a dead data silo but a fully trustworthy solution to bring their healthcare to a new level and make them the owner and director of their private medical data.

image

MEDICAL TOURISM & THE BLOCKCHAIN

Medical tourism is emerging all around the globe, with countries like Turkey, India, Thailand and even European nations competing to offer a wide range of specialized medical treatments. These offerings are ideal for patients who want quality and cost-effective medical care. This trend towards medical tourism is driven by an increasing access to high-quality care and services in low-cost countries or lack of availability and affordability of treatments in a patient‘s homeland. How is Aimedis strategically positioned to take advantage of this unique situation?

We not only establish the connection between patient and care provider, but we also compare prices and get the best deal for the patient, making it easier than ever to find the care needed. We also store and keep all the related information inside the patients’ records and connect the patients’ treating doctors before, during and after the intended procedures. This practice ensures transparency for the patient inside the AIMChain 2.0 by making the patients’ data incorruptible and 100% genuine. It also guarantees the integrity and security of the transaction and the procedure for the patient, enhancing both safety and results.

image

AIMSOCIAL – DECENTRALIZED & INCENTIVIZED MEDICAL SOCIAL NETWORKING

AIMSocial is our medical social media platform. It creates a space where patients support each other to live a happier and healthier life. Within this robust community, patients can share their experiences with diseases, effects of treatments and all kinds of information about health issues, wellness and nutrition. That’s where Aimedis finally combines empiric medical data with perceived data by the community bringing healthcare professionals together with the swarm intelligence of patient groups to reach new levels of medical support and quality.

We know of a variety of chronic diseases where in a lot of health cases people benefit more from talking with and learning from other similarly affected people than they do from talking to doctors and nurses. They can share subjective experiences with therapies, drugs and symptoms, as well as situations of everyday life with partners, family and environment. Learning to cope with a family member with dementia is a common challenge. After a diagnosis, caregivers begin looking for information and for others who have already dealt with the same experience for advice andknowledge. For those facing a harsh diagnosis or unexpected trauma and recovery, a community of peers becomes a lifeline to help to deal with the condition and navigate through new treatments and protocols.

The impact of health information delivered via mobile applications is vital, especially in regions with poor infrastructure. Many studies report significant drops in HIV-infections after people are informed about risks and prevention. Education and awareness can be enhanced by health professionals using the social media platform to reach out to people both near and far. Individuals that contribute useful information to others and create a community of followers will be incentivized. Building a community of responsible, supportive and caring people will be one of our major efforts. The Aimedis Social Medical Network also consists of medical influencers, that are doctors, nurses or healthcare specialists from other fields of healthcare to support patients via videos, streams, content and more. The Aimedis blockchain plays a major role when it comes to securing and incentivizing people for their efforts.

AIMSOCIAL – REDEFINING YOUR PERSPECTIVE ON HEALTHCARE

The unique source of information containing academic medicine and the knowledge of patients will help expanding the view professionals have on patients. Yet the basis of professional suggestions in health care are generally based on scientifically defined protocols and the experience of medical professionals while the input of patients’ experiences still can´t be included adequately and integrated into therapy protocols. Our platform will allow to easily overview the experiences on specific medical strategies from a view of perceived value reflected by groups of patients and combine them with the classical parameters and recommendations. Artificial intelligence will, based on the results and parameters, generate completely new insights and will change certain ways of treatments dramatically. Self-aid groups are a key element of today’s healthcare systems. They often support patients in a totally different way, as they allow patients to understand how other affected persons experience their disease and cope with it, which most of the time is something, doctors or psychologists cannot achieve.

European surveys show that 8 in 10 persons believe that self-aid groups are a very meaningful addition for healthcare and for patients’ treatments – a fact which gives these groups an equal position next to hospital treatments, ambulatory and rehabilitative measures and makes them the 4th column of healthcare. AIMsocial allows patients to rate all aspects, procedures and therapies concerning their conditions and to comment them, which is then saved and evaluated in a chronological order to compare it to other patients’ recordings inside the social medical network. Besides the gain of information patients experience the crowd’s support and input as a strong assistance on their way, which results in a much better handling of their conditions, both mentally and physically. Besides that, Aimedis generates a new source of information for scientific research to better diagnose and treat diseases by combining the crowd intelligence with latest healthcare insights and trials. Up to now patients’ inputs, experiences and their way of coping e.g., with chronic conditions are insufficiently taken in account when it comes to improvements of insights about medical conditions.

Imagine you trace a chronically ill patient’s condition over a certain period of time, observing her/his behaviour, nutrition, environment or motion patterns and combine that with medical and scientific insights and ecological factors. After that you compare this information with thousands of patients’ inputs. What you will get are groundbreaking and more precise perceptions which thus results in a new kind of medical care.

AIMEDIS DATAXCHANGE – NFT MARKETPLACE MONETIZING AND MAINSTREAMING MEDICAL DATA

The world’s first medical and scientific NFT marketplace will finally mainstream and standardize the process of monetizing medical and scientific data and thus will open and expand this multi-trillion-dollar market to the world. The unique AImedis NFTs generate simple and well-organized sets of data, always immutable, easy to follow up on the blockchain while keeping the sources of the data strictly anonymous and participating every stakeholder in the process in the revenues.

Revenues that can now be calculated and predicted as the price of medical and scientific data can finally be calculated, introducing a new standard of medical and scientific data. New data sources and buyers like AI companies, space agencies, car manufacturers, medical hardware sellers, IoT providers, healthcare institutions even out of reach of any classical research process will participate and contribute to this unique new B2B option that will change and improve the lives of millions of people all around the globe – and in space.

image

THE BUSINESS MODEL – VIRTUAL HOSPITAL & REHAB

Aimedis Virtual hospital will make it simple and cost effective to step into the future of hospital and practice information systems. Aimedis Virtual Hospital and Rehab are a fix part of the Aimedis ecosystem and are monetized via a simple Software-as-a-Service (SAAS) model.

For hospitals and practices around the world that means:

  • No expensive onboarding costs
  • Real time security monitoring
  • No untransparent update contracts and fees
  • Always being up to date without additional costs while offering
  • A simple per patient subscription model
image

AIMEDIS DIGITAL ASSET (AIMX TOKEN)- STRUCTURE, DISTRIBUTION & TOKENOMICS

  • ASSET TYPE: Token on Binance Smart Chain
  • MAXIMUM SUPPLY: 600.000.000 tokens
  • AVAILABLE FOR PURCHASE: 135.000.000 tokens
  • PRICE PER ASSET: 0,05 USD = 1 AIMX
  • 10% DISCOUT : on services paid with the AIMX token
  • EMISSION RATE: No new tokens will be minted, created or mined after the sale
  1. Staking: 1 Stake = 200,000 AIMx. A min. of 200k AIMx is required to participate in staking program. Stake for 12 months, receive 12.5% interest in AIMx. E.g.: User A stakes 200.000 AIMx for 12months => 12,5% interest (25.000 AIMx Tokens). Lockup time for staking is at least 6 months.
  2. Burning: 2% of existing AIMx tokens are burned per year for 5 years. Afterwards decentralized governance will decide about the continuation of the burning program.
  3. Spending: AIMx gives patients/users 10% discount on services when used in payments. Healthcare providers & companies receive up to 50% discount on advertising costs on the platform, if they hold a min. of 1 stake (200k AIMx). Pharmacies can access business deals within the Aimedis ecosystem if they hold a min. of 1 stake (200k AIMx). Users can use AIMx to get enable social medical functions.
  4. Earning: AIMx rewards for social medical activities (users, creators, vloggers, influencers, moderators, surveys, focus groups); AIMx donations for Nonprofits or goodwill initiatives (Africa, Philippines, Malaysia); AIMx funding for creatives projects to spread awareness (HIV/AIDS, rare diseases, etc); Advocacy programs for workplaces (hospitals, clinics, pharmacies) where participants can raise their Aimedis score and AIMx to unlock premium features (e.g. staffing premium services); earn AIMx, perks, and premium access by building local communities as an Aimedis ambassador.

Patients and data providers like research facilities or CROs can share their data with healthcare institutions, pharmaceutical companies and insurance companies via the unique Aimedis medical and scientific data NFTs. Thus patients can also participate in medical trials strictly organized through the Aimedis ecosystem. Sharing data is ALWAYS voluntary and NEVER mandatory.

Patients and data providers are being paid for sharing the data via the NFTs. They can earn Aimedis Token (AIMX token) for sharing their data with Aimedis STRICTLY ANONYMOUSLY, and get % discounts to services on Aimedis.

Aimedis uses ANONYMOUS shared medical data for huge medical online trials – this data is ALWAYS anonymized and the company can sell this data to the pharmaceutical industry and research organizations.

AIMx rewards participants in the Aimedis social healthcare ecosystem, which includes video and chat groups, blogs, pods and medical influencers. Rewards for participating in the healthcare company provided group discussions, surveys and tests. Content creators can use AIMx to enable premium features to publish their content.

Rewards for end users who opt-in to receive advertisement. Use AIMx for donations to healthcare non-profits in the Aimedis ecosystem. AIMx can be used as a ticket system to access certain AIMx social sections. Rewards for an Aimedis ambassador program to build local communities (support, elearning, focus groups, patient / doctor / nurse communities, medical-condition specific i.e. diabetes community ambassadors).

Funding of content creators in the network, creative contests, art to spread awareness about medical conditions, to fight bias against HIV/AIDS, STDs etc. with AIMx. Dedicated advocacy programs for private hospitals to motivate and enable your hospital’s medical staff to create content and show what the work environment is like, with colleagues, facilities, technology and medical equipment, and life at the hospital.

For each content created (videos, photos, blog posts, stories), your institution receives an advocacy score, while medical staff is rewarded in tokens. The advocacy score will help to be awarded in terms of workplace ethics, diversity, inclusion – which unlocks medical staffing discounts; while the medical staff can use the tokens to unlock premium features. Patients & staff can also vote for their favourite hospital, based on different factors.

image

THE AIMEDIS ROADMAP UNTIL 2022

  • Q1 2020 – Aimedis V2 Launched
  • Q2 2020 – AIMChain 2.0 launched
  • Q3 2020 – Aimedis platform registered as medical product CE certificate
  • Q4 2020 – Aimedis V3 launched & apps updated
  • Q4 2020 – Aimedis staff & HR launched
  • Q3 2020 – Aimedis iOS & Android apps released
  • Q1 2021 – New Aimedis blockchain protocol and AIMx
  • Q1 2021 – Launch of Aimedis labs
  • Q2 2021 – Launch of Aimedis Virtual Hospital
  • From 2022 – Launch of Aimedis Social Media Network (AIMSocial)
  • Q3/Q4 2021 – Aimedis eShop & Pharmacy
  • Q3/Q4 2021 – Launch of Aimedis DataXChange NFTs & data trading

Useful Links :

Author

Bitcointalk Username: Alvaro Odriozola
BitcoinTalk Profile URL: https://bitcointalk.org/index.php?action=profile;u=2852558
Telegram Username: https://t.me/yaqdhan15
Wallet : 0xf0fAf8D576082eC4B24a0A7e7671fAaf75fDB219

Komentar

Posting Komentar